Who would "He" be? LOL It won't stay under a penny long but there is a ton of debt eligible to convert at .001 if it ever manages to get to that level with volume.
Manipulation and naked short sales is what we always hear when these stinky pink companies fail. Not the inability to pay the toxic debt from the two previous treatment center failures, bad management, or flawed business model that doesn't generate much cash flow.
They borrowed more money from Leonite in Q2 that was due in Q2 and went unpaid. The "professional fees" burn rate that is much higher than previous years tells the story in my opinion. The now $3.9 million in series "n" notes are in default along with others as of Q2. The price continues to decline because buyers are placing their bets on the many other beaten down tickers that do have potential.
Between January 28, 2019 and June 11, 2020, the Company closed several tranches of Series N Convertible notes in which it raised $3,229,000 in principal...
The series N convertible notes matured and are in default. The Company is considering its options to settle these notes.
LXR Biotech
On April 12, 2019, the Company, entered into a secured Promissory Note in the aggregate principal amount of CDN$133,130. The Note had a maturity date of April 11, 2020...
This note has not been repaid, is in default and remains outstanding.
Ed Blasiak
On September 14, 2020, the Company entered into a Securities Purchase Agreement with Ed Blasiak (“Blasiak”), pursuant to which the Company issued a senior secured convertible promissory note in the aggregate principal amount of $55,000...
The note has matured and is in default, Ed Blasiak has not declared a default under the note and we are in communication with Mr. Blasiak on our ability to repay the note.
Leonite Capital, LLC
Secured Promissory Notes
On March 1, 2022, the Company entered into a secured Promissory Note in the aggregate principal amount of $124,000 for net proceeds of $100,000 after an original issue discount of $24,000. The Note had a maturity date of April 1, 2022. This note has not been repaid at the date of this report and no default has been declared.
On May 3, 2022, the Company, entered into a secured Promissory Note in the aggregate principal amount of $76,250 for net proceeds of $61,000 after an original issue discount of $15,250. The Note had a maturity date of June 17, 2022 and bears interest at the rate of zero percent per annum from the date on which the Note was issued until the same became due and payable.
We are in discussions with Leonite on the repayment of these notes.
14. Receivables Funding
On May 31, 2022 the Company, through its 75% held subsidiary, Evernia Health Center, LLC entered into a Receivables Sale Agreement with Itria Ventures LLC (“Itria”), whereby $240,000...
News 
Market Data 
Discover 
